Letters to the Editor: Banning Kratom Would Just Deprive Many Patients of Opioid-Free Relief
To the editor: The Food and Drug Administration’s call to classify 7-hydroxymitragynine (7-OH) as a Schedule I drug is unwarranted (“What to know about synthetic kratom, the supplement being banned in SoCal and across the U.S.,” Aug. 20). 7-OH is a natural extract from the kratom plant and the vast majority of deaths linked to use involved other drugs or contaminants. Regulators have not presented sufficient evidence of harm, yet they propose a ban that would deprive patients of relief.










